- Research works
- 21 ▲ 2597% vs 2013–17
- Citations
- 652 31.0 per fractional work
- Top-10% rate
- 36.3% record average 16.5%
- Open access
- 76% world 28%
Not ranked overall: Singleron Biotechnologies (china) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.8×. Every wedge is a field page.
Which keywords describe research at Singleron Biotechnologies (china)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, RNA-Seq, Cancer, Targeted Therapy, Single-Cell, Transcriptomics, Cancer Genomics and Mutational Signatures.
- Mutational Signatures
- Transcriptomics
- Targeted Therapy
- RNA-Seq
- Gene Expression
- Cancer
- Single-Cell
- Cancer Genomics
- Inflammation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Gene Expression3▲ 22×9 topics
- RNA-Seq2▲ 112×2 topics
- Cancer2▲ 6.6×11 topics
- Targeted Therapy2▲ 38×3 topics
- Single-Cell2▲ 361×1 topic
- Transcriptomics2▲ 361×1 topic
- Cancer Genomics1▲ 114×1 topic
- Mutational Signatures1▲ 114×1 topic
- Inflammation1▲ 2.4×7 topics
Which research topics does Singleron Biotechnologies (china) publish most on?
By volume in 2022–2025: Single-cell and spatial transcriptomics, Cancer Genomics and Diagnostics, Immune cells in cancer and Acute Myeloid Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 2 Cancer Genomics and Diagnostics Cancer Research 1 works
- 3 Immune cells in cancer Immunology 1 works
- 4 Acute Myeloid Leukemia Research Hematology 0 works
- 5 Genomics and Phylogenetic Studies Molecular Biology 0 works
- 6 Endometriosis Research and Treatment Reproductive Medicine 0 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Cancer Cells and Metastasis Oncology 0 works
- 9 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 0 works
- 10 Reproductive System and Pregnancy Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Singleron Biotechnologies (china)'s research output changed?
Output in 2018–2022 was 2597% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nanjing
- Southeast University
- Nanjing University
- Nanjing University of Aeronautics and Astronautics
- Nanjing University of Science and Technology
- Hohai University
- Nanjing Medical University
- Nanjing Tech University
- Nanjing Agricultural University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.